NCT02968134View on ClinicalTrials.gov

Single Dose Population Pharmacokinetics of Intravenous Posaconazole in Critically Ill Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

January 16, 2017

Primary Completion Date

May 21, 2017

Study Completion Date

May 21, 2017

Conditions
Systemic Fungal Infections
Interventions
DRUG

Posaconazole

A single dose of 300mg intravenous posaconazole will be administered and blood samples will be taken prior to start of infusion, at 15,45,75minutes, 3,5,8,12,18,24,30,36 and 48 hours.

All Listed Sponsors
collaborator

The University of Queensland

OTHER

lead

Royal Brisbane and Women's Hospital

OTHER_GOV

NCT02968134 - Single Dose Population Pharmacokinetics of Intravenous Posaconazole in Critically Ill Patients | Biotech Hunter | Biotech Hunter